By Tessa Eskin Big Pharma is at a crossroads. The industry’s business model relies largely on returning customers for its revenue, especially when it comes to medication for mental health disorders. To this day, there...
Category - Psychedelic Advocacy
The Three Biggest Challenges Facing the Psychedelics Sphere
By Jake Sherman Psychedelics have come a long way in the last 20 years. For proof of that, simply look to the growing number of companies in the space. Clinical trials are in advanced stages for a host of therapies that...